Form 4: Agenus CEO Garo Armen Opts for Stock-Based Salary, Acquires 2,745 Shares

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 2,745 shares of common stock valued at $5.96 per share as part of his salary for the pay period ending July 25, 2025.

Summary

• Garo H. Armen, Chairman and Chief Executive Officer of Agenus Inc., acquired 2,745 shares of Agenus Common Stock.
• The acquisition occurred on July 25, 2025, at a price of $5.96 per share.
• The shares were issued as payment for Dr. Armen's salary, in lieu of cash, at his request and with the approval of the Agenus Inc. Compensation Committee.
• The shares are fully vested on the date of issuance.
• Following this transaction, Dr. Armen directly beneficially owns 263,904 shares of Common Stock.
• Dr. Armen also indirectly beneficially owns 31,298 shares in his IRA accounts and 28,950 shares through the Garo Armen 2020 2 Year AG GRAT and Pixie Partners.

Sentiment

Score: 8

Explanation: The sentiment is positive due to the CEO's decision to take salary in stock, indicating strong confidence in the company's future and aligning management's interests with shareholders.

Positives

• The Chairman and CEO opting to receive salary in stock instead of cash demonstrates strong confidence in the company's future performance and aligns his interests with shareholders.
• The shares acquired are fully vested upon issuance, indicating immediate ownership and commitment.

Management Comments

• Garo H. Armen's salary is being paid in stock, in lieu of cash, at his request and with the approval of the Agenus Inc. Compensation Committee.

Related Party Transactions

• The transaction involves the company paying its Chairman and CEO, Garo H. Armen, in common stock as part of his compensation, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the CEO's decision to accept stock as salary as a positive signal of management's belief in the company's long-term value, potentially increasing investor confidence.
• Employees are not directly impacted by this specific transaction, but it reflects the company's compensation strategy for executives.

Key Dates

Recommendation

The Chairman and CEO's decision to receive salary in company stock, rather than cash, is a strong vote of confidence in Agenus Inc.'s future performance. This action aligns management's financial interests directly with those of shareholders, suggesting a positive outlook from an insider perspective. Such insider buying, even through compensation, often signals potential upside and warrants a 'buy' recommendation for investors looking for companies with strong management conviction.

Keywords

Agenus, AGEN, Garo Armen, Insider Transaction, Form 4, Stock Compensation, CEO Salary, Biotechnology, Pharmaceuticals, Equity Incentive Plan